GSA CAPITAL PARTNERS LLP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$402
-74.6%
126,812
-49.6%
0.03%
-82.7%
Q4 2022$1,581
-99.5%
251,384
+689.4%
0.20%
+326.1%
Q3 2022$344,000
-74.6%
31,846
-78.6%
0.05%
-74.7%
Q1 2022$1,356,000
-20.8%
148,804
+29.6%
0.18%
-15.3%
Q4 2021$1,713,000
+370.6%
114,815
+723.0%
0.22%
+424.4%
Q2 2021$364,000
+27.7%
13,951
+23.8%
0.04%
-12.8%
Q4 2020$285,000
+3.3%
11,273
+6.1%
0.05%
+46.9%
Q4 2019$276,00010,6220.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders